Carasent AB (publ) (STO:CARA)
24.95
+0.09 (0.34%)
At close: May 2, 2025
Carasent AB Revenue
Carasent AB had revenue of 85.18M NOK in the quarter ending March 31, 2025, with 28.88% growth. This brings the company's revenue in the last twelve months to 294.35M, up 17.12% year-over-year. In the year 2024, Carasent AB had annual revenue of 275.26M with 12.27% growth.
Revenue (ttm)
294.35M NOK
Revenue Growth
+17.12%
P/S Ratio
6.39
Revenue / Employee
1.48M NOK
Employees
199
Market Cap
1.79B SEK
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 275.26M | 30.08M | 12.27% |
Dec 31, 2023 | 245.18M | 49.92M | 25.57% |
Dec 31, 2022 | 195.26M | 58.14M | 42.40% |
Dec 31, 2021 | 137.13M | 66.55M | 94.29% |
Dec 31, 2020 | 70.58M | 22.65M | 47.26% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.30B |
Getinge AB | 35.57B |
Camurus AB | 1.87B |
Medicover AB | 23.56B |
AddLife AB | 10.42B |
Vitrolife AB | 3.61B |
Vimian Group AB | 4.24B |